Suppr超能文献

与单独使用专用PET相比,集成式PET-CT在非小细胞肺癌患者分期中的准确性。

The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

作者信息

Cerfolio Robert James, Ojha Buddhiwardhani, Bryant Ayesha S, Raghuveer Vanguru, Mountz James M, Bartolucci Alfred A

机构信息

Section of Thoracic Surgery, University of Alabama at Birmingham, and Division of Cardiothoracic Surgery, Department of Surgery, Birmingham Veterans Administration Hospital, Birmingham, Alabama 35294, USA.

出版信息

Ann Thorac Surg. 2004 Sep;78(3):1017-23; discussion 1017-23. doi: 10.1016/j.athoracsur.2004.02.067.

Abstract

BACKGROUND

The treatment of patients with nonsmall cell lung cancer (NSCLC) is determined by the stage. We evaluated the accuracy of staging using integrated positron emission tomography (PET) and computed tomography (CT) and compared it with dedicated PET visually correlated with CT scan.

METHODS

A prospective blinded trial was performed on a consecutive series of patients with NSCLC. Patients underwent integrated PET-CT scanning with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG-18). A radiologist assigned the T, N and M status. No sooner than 2 weeks the same radiologist read the dedicated PET alone, without the integrated CT images and a T, N and M status was assigned again. The most recent CT scan was available and visually correlated with both studies. All patients underwent biopsies of suspicious N2 or N3 lymph node or distant metastases and if negative, pulmonary resection with lymphadenectomy was performed.

RESULTS

There were 129 patients. Integrated PET-CT is a better predictor than PET for all stages of cancer and achieved statistical significance for stage I (52% versus 33%, p = 0.03) and for stage II (70% versus 36%, p = 0.04). It also is a better overall predictor for T status (70% versus 47%, p = 0.001) and the N status (78% versus 56%, p = 0.008). Nodal analysis shows that integrated PET-CT was more accurate for the total N2 nodes (96% versus 93%, p = 0.01) and for the total N1 nodes (90% versus 80%, p = 0.001). It was also more sensitive, specific, and had a higher positive predictive value for both N2 and N1 nodes (p < 0.05 for all). Integrated PET-CT is significantly more sensitive at the 4R, 5, 7, 10 L and 11 stations and more accurate at the 7 and 11 lymph nodes stations than dedicated PET.

CONCLUSIONS

Integrated PET-CT using FDG-18 better predicts stage I and II disease as well as the T and N status of patients with NSCLC when compared with dedicated PET alone. It is more accurate at some nodal stations but still only achieves an accuracy of 96% and 90% for the N2 and N1 nodes, respectively.

摘要

背景

非小细胞肺癌(NSCLC)患者的治疗方案取决于疾病分期。我们评估了采用正电子发射断层扫描(PET)与计算机断层扫描(CT)融合成像进行分期的准确性,并将其与PET和CT扫描图像视觉关联的专用PET进行比较。

方法

对一系列连续的NSCLC患者进行前瞻性盲法试验。患者接受了2-[18F]-氟-2-脱氧-D-葡萄糖(FDG-18)PET-CT融合扫描。一名放射科医生确定T、N和M分期。在不早于2周后,同一名放射科医生仅阅读专用PET图像,不看融合的CT图像,再次确定T、N和M分期。可获得最新的CT扫描图像,并与两项研究的图像进行视觉关联。所有患者均对可疑的N2或N3淋巴结或远处转移灶进行活检,若活检结果为阴性,则进行肺切除及淋巴结清扫术。

结果

共有129例患者。对于癌症的所有分期,PET-CT融合成像比专用PET具有更好的预测能力,在I期(52%对33%,p = 0.03)和II期(70%对36%,p = 0.04)达到统计学显著性。对于T分期(70%对47%,p = 0.001)和N分期(78%对56%,p = 0.008),PET-CT融合成像也是更好的总体预测方法。淋巴结分析显示,PET-CT融合成像对总的N2淋巴结(96%对93%,p = 0.01)和总的N1淋巴结(90%对80%,p = 0.001)更准确。对于N2和N1淋巴结,PET-CT融合成像也更敏感、特异,且具有更高的阳性预测值(所有p < 0.05)。与专用PET相比,PET-CT融合成像在4R、5、7、10L和11区显著更敏感,在7区和11区淋巴结更准确。

结论

与单独使用专用PET相比,采用FDG-18的PET-CT融合成像能更好地预测NSCLC患者的I期和II期疾病以及T和N分期。在某些淋巴结区域它更准确,但对于N2和N1淋巴结的准确率仍仅分别为96%和90%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验